期刊文献+

广西2007-2012年结核分枝杆菌和艾滋病病毒联合感染患者死亡特征分析 被引量:7

Feature analysis on patients died from co-infection of Mycobacterium tuberculosis and human immunodeficiency virus in Guangxi,from 2007 to 2012
原文传递
导出
摘要 目的:了解2007-2012年广西结核分枝杆菌(MTB)/HIV联合感染患者死亡特征,为有效控制联合感染提供科学依据。方法收集整理2007-2012年广西死因登记系统(VRS)中根本死因为HIV造成MTB感染死亡的个案及死因诊断为结核病(TB)的患者,核对病例在TB专报系统的实验室检测结果、诊断时间、发病时间等信息;用统计学方法统计分析病例的三间分布、死亡平均年龄、从发病到死亡时间间隔等特征。结果2007-2012年广西VRS登记的HIV死亡患者中,203例因感染MTB死亡,MTB/HIV联合感染死亡患者占同期AIDS、TB死亡患者的平均比例为8.24%(3.94%~13.27%)和9.90%(2.56%~26.88%)。2010-2012年,MTB/HIV死亡患者占同期AIDS、TB死亡患者的平均比例上升到10.66%和22.17%;MTB/HIV联合感染死亡患者男女比例为4.21∶1;平均死亡年龄为44.65(44.65±15.52)岁;从TB发病到诊断时间M为37(94.31±206.07)d;从诊断到死亡平均间隔M为46(165.22±282.19)d;54.68%的MTB/HIV患者在诊断TB 2个月内死亡;从发病到死亡时间M为131(257.68±340.79)d;16.26%的联合感染死亡患者被细菌学确诊为TB病例。结论细菌学确诊的MTB/HIV患者比例少于HIV阴性TB患者;而MTB导致的联合感染死亡患者占同期AIDS、TB死亡比例较大,且近3年增加明显,需要增加抗病毒治疗覆盖面;大部分联合感染患者诊断TB后很快死亡,应尽早在HIV患者中发现TB患者。 Objective To understand the general feature of patients with Mycobacterium tuberculosis(MTB)and human immunodeficiency virus(HIV)co-infectious(TB/HIV)in Guangxi, from 2007 to 2012. Methods Information regarding individuals that the contributory causes of death were due to MTB infection among HIV as the underlying cause of death from the Vital Registration System,together with bacterium smear or culture results,onset of TB,time that TB was diagnosed and entered an Internet base TB surveillance system was collected and checked. Data including information on time of death,age,occupation,the underlying cause of death among TB patients, bacterium distribution,average age of death,interval from onset to death,percentage of TB/HIV co-infection patients among all the patients etc,were all analysed. Results 203 patients died from HIV associated with TB from the Guangxi Vital Registration System were identified between 2007 and 2012. The average percentage of TB/HIV co-infection cases accounted for 8.24%(ranging from 3.94%in 2007 to 13.27%in 2012)among all the deaths of HIV infection while it accounted for 9.90%(ranging from 2.56%to in 2007 to 26.88%in 2012)among patients with MTB infection in the same period. The average percentage of deaths from TB/HIV co-infection in 2010 and 2012 accounted for 10.66%(ranging from 8.83% to 13.27%) and 22.17%(ranging from 20.60% to 26.88%) among patients died of HIV and TB infection respectively. The male-female ratio was 4.21 for 1,with the average age of death as 44.65 (44.65 ± 15.52)years;median time from TB symptoms onset to diagnosis as 37(mean 94.31,standard deviation 206.07)days,record as(94.31 ± 206.07);median time from diagnosis to death as 46(165.22 ± 282.19)days,54.68%TB/HIV patients died within two months of being diagnosed with TB and the median time from TB symptoms onset to death as 131 (257.68 ± 340.79) days. 16.26% of the TB/HIV cases were bacterium confirmed TB cases. Conclusion Compare to those TB patients without HIV,less bacterium evidence was found in TB/HIV patients. High burden caused by HIV disease was seen if they were co-infected with TB. An increasing proportion of deaths was noticed among patients co-infected with HIV and TB in the last three years,suggesting that the coverage of antiretroviral therapy be scaled up together with the strengthening of the capability on early TB case-finding among people live with HIV.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2014年第6期695-698,共4页 Chinese Journal of Epidemiology
关键词 艾滋病 结核病 联合感染 死亡 HIV/AIDS Tuberculosis Co-infection Death
作者简介 通信作者:耿文奎,Email:gxnngengwk@163.com
  • 相关文献

参考文献22

  • 1Lawn SD,Churchyard G.Epidemiology of HIV-associated tuberculosis [ J ].Curr Opin HIV AIDS,2009,4(4):325-333.
  • 2Shafer RW,Edlin BR.Tuberculosis in patients infected with human immunodefieiency virus:perspective on the past decade [J].Clin Infect Dis,1996,22(4):683-704.
  • 3Corbett EL,Watt CJ,Walker N,et al.The growing burden of tuberculosis:global trends and interactions with the HIV epidemic [ J ].Arch Intern Med,2003,163(9):1009-1021.
  • 4WHO.Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in settings [R].Department of HIV/AIDS stop TB department World Health Organization,Geneva:Switzerland,2011.
  • 5WHO.Global Tuberculosis Report 2013[R].World Health Organization,Geneva:Switzerland,2013.
  • 6International statistical classification of diseases and related health problems [M].10^th revision(ICD-10),2^nd ed.Geneva:World Health Organization,2007.
  • 7WHO.WHO Health STATISTICS,2013 [R].World Health Organization,Geneva:Switzerland,2013.
  • 8Lucejko M,Grzeszczuk A,Rogalska M,et al.Incidence of tuberculosis and mycobacteriosis among HIV-infected patients-clinical and epidemiological analysis of patients from north-eastern Poland [J].Pneumonol Alergol Pol,2013,81(6):502-510.
  • 9广西统计局.广西统计年鉴[M].北京:中国统计出版社.2013.
  • 10Rojpibulstit M,Kanjanakiritamrong J,Chongsuvivatwong V.Patient and health system delays in the diagnosis of tuberculosis in Southern Thailand after health care reform [J].Int J Tuberc Lung Dis,2006,10(4):422-428.

共引文献1

同被引文献80

  • 1于军,苏学今,王丽.射干、金银花等八种中药抗真菌实验研究[J].军医进修学院学报,2007,28(4):299-300. 被引量:31
  • 2张福杰,王健,王福生,等.国家免费艾滋病抗病毒药物治疗手册[M].3版.北京:人民卫生出版社,2012:183-185.
  • 3WHO. Guidelines for Intensified Tuberculosis Case-finding and Isoniazid Preventive Therapy for People Living with HIV in Settings [ R ]. Geneva: WHO, 2011.
  • 4Akksilp S, Karnkawinpong O, Wattanaamornkiat W, et al. Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand [J]. Emerg Infect Dis, 2007,13 (7) : 1001-1007.
  • 5Cain KP, Kanara N, Laserson KF, et al. The epidemiology of HIV-associated tuberculosis in rural Cambodia [J]. Int J Tuberc Lung Dis,2007,11 (9) : 1008-1013.
  • 6Manosuthi W, Chottanapand S, Thongyen S, et al. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy [J]. J Acquir Immune Defic Syndr, 2006,43( 1 ) :42-46.
  • 7Harries AD, Lawn SD, Getahun H, et al. HIV and tuberculosis- science and implementation to turn the tide and reduce deaths [J]. Int AIDS Soc,2012,15(2) : 17396.
  • 8WHO. Global Tuberculosis Control [ R ]. Geneva: WHO, 2011.
  • 9Lawn SD, Harries AD, Williams BG, et al. Antiretroviral therapy and the control of H1V-associated tuberculosis. Will ART do it? [J]. Int J Tuberc Lung Dis, 2011,15(5) :571-581.
  • 10Murphy RA, Sunpath H, Taha B, et al. Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa [J]. Int J Tuberc Lung Dis,2010,14(7) :903-908.

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部